Clinical data | |
---|---|
Other names | (2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C28H27Cl2N3O7S |
Molar mass | 620.50 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Relcovaptan (SR-49059) is a non- peptide vasopressin receptor antagonist, selective for the V1a subtype. [1] It has shown positive initial results for the treatment of Raynaud's disease and dysmenorrhoea, and as a tocolytic, [2] although it is not yet approved for clinical use.
Clinical data | |
---|---|
Other names | (2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C28H27Cl2N3O7S |
Molar mass | 620.50 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Relcovaptan (SR-49059) is a non- peptide vasopressin receptor antagonist, selective for the V1a subtype. [1] It has shown positive initial results for the treatment of Raynaud's disease and dysmenorrhoea, and as a tocolytic, [2] although it is not yet approved for clinical use.